Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

199 public trials 69 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

NCT07206225

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • UAB Infusion Therapy Extended Care Clinic (ECC) Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Investigation Drug Services Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 68 locations
View Trial Details
Recruiting

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

NCT05126472

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

NCT07144319

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Oslo University Hospital Oslo, Norway
View Trial Details
Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

NCT04752722

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +16 more
Locations
  • The University of Alabama at Birmingham Clinical Research Unit (CRU) Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Urological Associates of South Arizona Tucson, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 102 locations
View Trial Details
Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

NCT06995677

Conditions
Carcinoma, FGFR Gene Alterations, FGFR Gene Amplification, +18 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Tri Valley Urology - Murrieta Murrieta, California, United States
  • Eisenhower Medical Associates Rancho Mirage, California, United States
View all 47 locations
View Trial Details
Recruiting

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

NCT05796375

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • West Haven VA Medical Center West Haven, Connecticut, United States
  • Bay Pines VA Healthcare System Bay Pines, Florida, United States
  • James A. Haley Veterans' Hospital Tampa, Florida, United States
  • VA Boston Jamaica Plains Campus West Roxbury, Massachusetts, United States
View Trial Details
Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

NCT07000084

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
View all 58 locations
View Trial Details

Related conditions